Filing Details
- Accession Number:
- 0001567619-18-008050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-14 19:16:46
- Reporting Period:
- 2018-11-30
- Accepted Time:
- 2018-12-14 19:16:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1128189 | Protokinetix Inc. | PKTX | Pharmaceutical Preparations (2834) | 943355026 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1516077 | Edward Clarence Smith | 1845 Country Road #214 St. Augustine FL 32084 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-11-30 | 70,000 | $0.08 | 4,816,802 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2018-11-30 | 40,000 | $0.09 | 4,856,802 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2018-12-03 | 5,000 | $0.09 | 4,861,802 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2018-12-04 | 13,000 | $0.09 | 4,874,802 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2018-12-06 | 2,000 | $0.09 | 4,876,802 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2018-12-07 | 27,000 | $0.08 | 4,903,802 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2018-12-11 | 27,000 | $0.08 | 4,976,352 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2018-12-13 | 72,550 | $0.07 | 4,976,802 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2018-12-14 | 44,223 | $0.08 | 5,021,025 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 57,020,500 | Direct | |
Common Stock | 1,850,000 | Indirect | See footnote |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $0.09 | 2023-11-08 | 5,000,000 | 5,000,000 | Direct | |
Common Stock | Stock Option | $0.06 | 2021-08-31 | 5,000,000 | 5,000,000 | Direct | |
Common Stock | Stock Option | $0.05 | 2020-12-31 | 5,000,000 | 5,000,000 | Direct | |
Common Stock | Stock Option | $0.08 | 2019-12-31 | 5,000,000 | 5,000,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2023-11-08 | 5,000,000 | 5,000,000 | Direct |
2021-08-31 | 5,000,000 | 5,000,000 | Direct |
2020-12-31 | 5,000,000 | 5,000,000 | Direct |
2019-12-31 | 5,000,000 | 5,000,000 | Direct |
Footnotes
- Shares held by the Clarence E. Smith Trust.
- Shares held by Mr. Smith's retirement account.
- Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan. On March 31, 2019, 1,250,000 shares vest; thereafter 1,250,000 shares vest each quarter.
- Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On December 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
- Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On March 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
- Options granted pursuant to 2015 Stock Option and Stock Bonus Plan. On March 31, 2016, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.